Viral evolutionary changes during tenofovir treatment in a chronic hepatitis B patient with sequential nucleos(t)ide therapy

被引:20
作者
Lee, Hyun Woong [1 ]
Chang, Hye Young [1 ]
Yang, Suh Yoon [1 ]
Kim, Hyung Joon [1 ]
机构
[1] Chung Ang Univ, Coll Med, Dept Internal Med, Seoul 156755, South Korea
关键词
Tenofovir; Chronic hepatitis B; Resistance; Mutation; SELECTION; FAILURE;
D O I
10.1016/j.jcv.2014.03.018
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A 54-year-old man diagnosed with HBeAg-positive chronic hepatitis B (CHB) was treated with entecavir (ETV) 1 mg/day following an initial unsuccessful lamivudine (LAM) treatment (rtL180M, rtM204V/I). Subsequently, virological breakthrough with ETV mutation (rtT184A/L) developed. The LAM and adefovir combination therapy was followed by virological breakthrough. The therapy had been switched to TDF monotherapy. However, this patient experienced virological breakthrough under TDF with a HBV strain bearing rtL80M, rtL180M, rtM204V/I, rtA200V, rtF221Y, rt5223A, rtT184A/L, rtR153Q, and rtV191I combined mutations without rtA194T mutation. TDF resistance may emerge due to multi-site polymerase mutations rather than single-site polymerase mutation. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:313 / 316
页数:4
相关论文
共 10 条
[1]   The rtA194T Polymerase Mutation Impacts Viral Replication and Susceptibility to Tenofovir in Hepatitis B e Antigen-Positive and Hepatitis B e Antigen-Negative Hepatitis B Virus Strains [J].
Amini-Bavil-Olyaee, Samad ;
Herbers, Ulf ;
Sheldon, Julie ;
Luedde, Tom ;
Trautwein, Christian ;
Tacke, Frank .
HEPATOLOGY, 2009, 49 (04) :1158-1165
[2]   Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus [J].
Delaney, WE ;
Ray, AS ;
Yang, HL ;
Qi, XP ;
Xiong, S ;
Zhu, YA ;
Miller, MD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (07) :2471-2477
[3]   Selection of chronic hepatitis B therapy with high barrier to resistance [J].
Gish, Robert ;
Jia, Ji-Dong ;
Locarnini, Stephen ;
Zoulim, Fabien .
LANCET INFECTIOUS DISEASES, 2012, 12 (04) :341-353
[4]   Convergence and coevolution of Hepatitis B virus drug resistance [J].
Hong Thai ;
Campo, David S. ;
Lara, James ;
Dimitrova, Zoya ;
Ramachandran, Sumathi ;
Xia, Guoliang ;
Ganova-Raeva, Lilia ;
Teo, Chong-Gee ;
Lok, Anna ;
Khudyakov, Yury .
NATURE COMMUNICATIONS, 2012, 3
[6]   EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection [J].
Papatheodoridis, George ;
Buti, Maria ;
Cornberg, Markus ;
Janssen, Harry ;
Mutimer, David ;
Pol, Stanislas ;
Raimondo, Giovanni .
JOURNAL OF HEPATOLOGY, 2012, 57 (01) :167-185
[7]   Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B [J].
Patterson, S. J. ;
George, J. ;
Strasser, S. I. ;
Lee, A. U. ;
Sievert, W. ;
Nicoll, A. J. ;
Desmond, P. V. ;
Roberts, S. K. ;
Locarnini, S. ;
Bowden, S. ;
Angus, P. W. .
GUT, 2011, 60 (02) :247-254
[8]   Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discovery [J].
Rhee, Soo-Yon ;
Margeridon-Thermet, Severine ;
Nguyen, Mindie H. ;
Liu, Tommy F. ;
Kagan, Ron M. ;
Beggel, Bastian ;
Verheyen, Jens ;
Kaiser, Rolf ;
Shafer, Robert W. .
ANTIVIRAL RESEARCH, 2010, 88 (03) :269-275
[9]  
Sheldon J, 2005, ANTIVIR THER, V10, P727
[10]   Long-Term Efficacy of Tenofovir Monotherapy for Hepatitis B Virus-Monoinfected Patients After Failure of Nucleoside/Nucleotide Analogues [J].
van Boemmel, Florian ;
de Man, Robert A. ;
Wedemeyer, Heiner ;
Deterding, Katja ;
Petersen, Joerg ;
Buggisch, Peter ;
Erhardt, Andreas ;
Hueppe, Dietrich ;
Stein, Kerstin ;
Trojan, Joerg ;
Sarrazin, Christoph ;
Boecher, Wulf O. ;
Spengler, Ulrich ;
Wasmuth, Hermann E. ;
Reinders, Jurrien G. P. ;
Moeller, Bernd ;
Rhode, Peter ;
Feucht, Heinz-Hubert ;
Wiedenmann, Bertram ;
Berg, Thomas .
HEPATOLOGY, 2010, 51 (01) :73-80